Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by X. Radu
Psy156 - Quids In? – A Review of Whether Potential Blockbuster Savings From Biosimilar Adalimumab Should Be Reinvested in Other Disease Areas?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Unenumerated Rights: Whether and How Roe Should Be Overruled
University of Chicago Law Review
Law
Rare Disease Landscape: Will the Blockbuster Model Be Replaced?
Expert Opinion on Orphan Drugs
Toxicology
Pharmaceutics
Pharmacology
Health Policy
Health Should Not Be a Determinative Factor of Whether One Will Be a Suitable Adoptive Parent
Indiana Health Law Review
Physicochemical and Functional Characterization of a Biosimilar Adalimumab ZRC-3197
Biosimilars
Flow Chart Helps in Deciding Whether School Occupational Therapy Services Should Be Continued
American Journal of Occupational Therapy
Medicine
Occupational Therapy
A Budget Impact Analysis of Adalimumab Biosimilar: The Italian Context
AboutOpen
Chronic Phase of Chagas Disease: Why Should It Be Treated? A Comprehensive Review
Memorias do Instituto Oswaldo Cruz
Medicine
Microbiology
A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501
Advances in Therapy
Medicine
Pharmacology
Book Review: Other Areas
Political Studies Review
Sociology
International Relations
Political Science